Silverio Tomao
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 175 publications
The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets.
Journal: Frontiers in oncology
Published: January 30, 2023
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study.
Journal: Frontiers in oncology
Published: January 27, 2023
The management of oligometastatic disease in colorectal cancer: Present strategies and future perspectives.
Journal: Critical reviews in oncology/hematology
Published: October 13, 2022
The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study.
Journal: Cancers
Published: September 07, 2022
Angioside: The role of Angiogenesis and Hypoxia in Lung Neuroendocrine Tumours According to Primary Tumour Location in Left or Right Parenchyma.
Journal: Journal of clinical medicine
Published: September 02, 2022
The value of the multidisciplinary team in metastatic renal cell carcinoma: Paving the way for precision medicine in toxicities management.
Journal: Frontiers in oncology
Published: August 24, 2022
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach.
Journal: Cancer immunology, immunotherapy : CII
Published: July 16, 2022
The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy.
Journal: Frontiers in immunology
Published: June 20, 2022
Sexual dysfunctions in breast cancer patients: evidence in context.
Journal: Sexual medicine reviews
Published: May 17, 2022
Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs): A Systematic Review and Pooled Analysis.
Journal: Cancer management and research
Published: May 17, 2022
Primary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet combination regimen including oxaliplatin and/or irinotecan plus fluoropyrimidines: A propensity score matched analysis.
Journal: Frontiers in oncology
Published: May 04, 2022
Last Updated: 09/26/2026